Latest filing published 02 Sept 2026 for BIOMERIEUX. Read the official filing
Not enough history yet: 0 closed purchases, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Yasha Mitrotti Ventura, listed as chief executive, appears in our data through filings on Biomerieux shares, published by AMF. In total, 9 filings cover trades dated from 26 February 2022 to 31 August 2026.
In open-market terms, that means 3 purchases on one side and 3 sales worth €615k on the other. The amount is not disclosed for 3 filings. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 3 share grants. Since January 2026: 1 purchase and no sales on the market.
Most recently, on 2 September 2026, the filings show an open-market purchase in Biomerieux. Typically, a trade is published a median of 2 days after it takes place. For comparison, MAR article 19 gives managers three business days to notify a trade. This summary is built from AMF disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations